UnknownNANCT07642830

Clinical Research of Digital Health Solutions for Patients With Type 2 Diabetes

Sponsor: Chang Gung Memorial Hospital

Trial Details

Condition	Diabetes Mellitus Type 2
Intervention	CGM
Phase	NA
Status	Unknown
Participants	60
Est. Completion	4 Jan 2027
Last Updated	11 June 2026

Primary Outcome

HbA1c; TIR

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: \- Patients with confirmed diagnosis of T2D for \>1 year, capable of using a smartphone, and willing to sign informed consent. Exclusion Criteria: * Patients with severe cardiac, hepatic, or renal disease; pregnant women; those participating in other experimental treatments; or unable to follow up.

Trial Sites

Countries

Taiwan

View Registry Entry

Related Analysis

Taiwan Digital Health Trial: CGM Plus Mobile Apps vs Standard Care in Type 2 Diabetes — 12-Week Outcomes Study

Taiwan researchers investigate whether continuous glucose monitoring combined with mobile health apps improves glycaemic control in type 2 diabetes patients compared to standard care. The 12-week study examines HbA1c and time in range outcomes.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service